Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NCLH vs GSK✓SelectedUSD · GSKNCLH vs GSK performance historyLatest closeAs of-0.33%11/16
Stock and ETF performance explorer

NCLH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+19.9%
GSK return
+62.7%
Excess return
-42.8%
Maximum drawdown
-51.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.3%-0.1%-0.3%-0.3%
7D-2.9%-1.3%-1.6%-2.7%
30D+18.9%+2.7%+16.2%+18.5%
3M-5.8%+2.7%-8.6%-6.2%
6M+15.3%+3.3%+12.0%+14.9%
YTD-19.8%+6.5%-26.3%-18.9%
1Y-2.1%+10.7%-12.8%-0.9%
All+19.9%+62.7%-42.8%+21.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling